Playback speed
10 seconds
Does COVID-19 Have a Predilection for CV Disease? Is Having High ACE2 Levels a Good Thing? Is There Enough Evidence to Support Treatment with Hydroxychloroquine?
By
Cardiometabolic Health Congress (CMHC)
FEATURING
Clyde Yancy
By
Cardiometabolic Health Congress (CMHC)
FEATURING
Clyde Yancy
35 views
May 22, 2020
Login to view comments.
Click here to Login